Arkolith/Insider Trading/LIXT/Form 4/A

van der Baan Bastiaan Jeroen

DirectorLIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) · full profile →Form 4/A · filed Jan 5, 2023
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 30, 2022Buy(P)10K$0.49$5K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001493152-23-000449) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML